...
首页> 外文期刊>The Lancet >Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study
【24h】

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study

机译:发展中国家婴儿和幼儿腹泻病的负担和缓解学(全球肠胃肠道多中心研究,宝石):一项潜在案例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Summary Background Diarrhoeal diseases cause illness and death among children younger than 5 years in low-income countries. We designed the Global Enteric Multicenter Study (GEMS) to identify the aetiology and population-based burden of paediatric diarrhoeal disease in sub-Saharan Africa and south Asia. Methods The GEMS is a 3-year, prospective, age-stratified, matched case-control study of moderate-to-severe diarrhoea in children aged 0-59 months residing in censused populations at four sites in Africa and three in Asia. We recruited children with moderate-to-severe diarrhoea seeking care at health centres along with one to three randomly selected matched community control children without diarrhoea. From patients with moderate-to-severe diarrhoea and controls, we obtained clinical and epidemiological data, anthropometric measurements, and a faecal sample to identify enteropathogens at enrolment; one follow-up home visit was made about 60 days later to ascertain vital status, clinical outcome, and interval growth. Findings We enrolled 9439 children with moderate-to-severe diarrhoea and 13猬129 control children without diarrhoea. By analysing adjusted population attributable fractions, most attributable cases of moderate-to-severe diarrhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin (ST-ETEC; with or without co-expression of heat-labile enterotoxin), and Shigella. Other pathogens were important in selected sites (eg, Aeromonas, Vibrio cholerae O1, Campylobacter jejuni). Odds of dying during follow-up were 8?-fold higher in patients with moderate-to-severe diarrhoea than in controls (odd ratio 8?, 95% CI 5?-12?, p<0?001); most deaths (167 [87?%]) occurred during the first 2 years of life. Pathogens associated with increased risk of case death were ST-ETEC (hazard ratio [HR] 1?; 0?9-3?) and typical enteropathogenic E coli (HR 2?; 1?-4?) in infants aged 0-11 months, and Cryptosporidium (HR 2?; 1?-4?) in toddlers aged 12-23 months. Interpretation Interventions targeting five pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can substantially reduce the burden of moderate-to-severe diarrhoea. New methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes. Funding The Bill & Melinda Gates Foundation.
机译:发明内容背景腹泻疾病在低收入国家5岁以下的儿童造成疾病和死亡。我们设计了全球肠道多中心研究(Gems),以确定撒哈拉以南非洲和南亚小儿腹泻疾病的疾病和人口。方法采用宝石是3年,前瞻性,年龄分层,匹配的差异,匹配案例调查研究,对居住在非洲四个地点和亚洲三个地点的持续群体中的中度至严重的腹泻。我们招募了患有中度至严重的腹泻的儿童,寻求健康中心的寻求护理,以及一到三个无随机选择的匹配群体控制儿童,没有腹泻。从中度至严重的腹泻和对照患者中,我们获得了临床和流行病学数据,人体测量测量和粪便样品以识别入学时的肠道病;大约60天后进行一次后续房屋访问,以确定重要地位,临床结果和间歇增长。调查结果我们注册了9439名儿童,中度至严重的腹泻,13‰129种没有腹泻的儿童。通过分析调整后的人口可归分数,中度至严重的腹泻的最具遗传案件是由于四种病原体:轮状病毒,密码孢子虫,肠毒素大肠杆菌生产热稳定的毒素(ST-ETEC;有或没有加热稳定的同步表达肠毒素)和志贺氏菌。其他病原体在选定的地点(例如,Aeromonas,Vibrio Cholerae O1,Campylobons jejuni)中是重要的。在随访期间死亡的几率为8? - 在中度至严重的腹泻患者中比在对照中的患者更高(奇数8?,95%CI 5 = -12〜12→P <0≤00);大多数死亡(167 [87?%])发生在生命的前2年。与病例死亡风险增加的病原体是ST-ETEC(危险比[HR] 1?; 0?9-3?)和典型的肠球疗法E Coli(HR 2?; 1?-4?)在0-11岁的婴儿在12-23个月的幼儿中,几个月和加密孢子虫(HR 2?; 1?-4?)。靶向五种病原体(RotaVirus,Shigella,ST-ETEC,Cryptosporimium,典型肠道致原肠杆菌)的解释干预率可以大大降低中度至严重腹泻的负担。需要新的方法和加速实施现有干预(RotaVirus疫苗和锌),以防止疾病和改善结果。筹集比尔和梅琳达盖茨基金会。

著录项

  • 来源
    《The Lancet》 |2013年第9888期|共14页
  • 作者单位

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Centre Pour le Développement des Vaccins Bamako Mali;

    National Institute of Cholera and Enteric Diseases Kolkata India;

    Global Disease Detection Division Kenya Office of the US Centers for Disease Control and;

    International Centre for Diarrhoeal Disease Research Mohakhali Dhaka Bangladesh;

    Department of Paediatrics and Child Health Aga Khan University Karachi Pakistan;

    Medical Research Council (UK) Unit Fajara Gambia;

    Centro de Investiga??o em Saúde da Manhi?a Maputo Mozambique Barcelona Centre for International;

    Centre Pour le Développement des Vaccins Bamako Mali;

    Centre Pour le Développement des Vaccins Bamako Mali;

    Centre Pour le Développement des Vaccins Bamako Mali;

    National Institute of Cholera and Enteric Diseases Kolkata India;

    National Institute of Cholera and Enteric Diseases Kolkata India;

    National Institute of Cholera and Enteric Diseases Kolkata India;

    Kenya Medical Research Institute/Centers for Disease Control and Prevention (KEMRI/CDC) Kisumu;

    Kenya Medical Research Institute/Centers for Disease Control and Prevention (KEMRI/CDC) Kisumu;

    Kenya Medical Research Institute/Centers for Disease Control and Prevention (KEMRI/CDC) Kisumu;

    International Centre for Diarrhoeal Disease Research Mohakhali Dhaka Bangladesh;

    International Centre for Diarrhoeal Disease Research Mohakhali Dhaka Bangladesh;

    International Centre for Diarrhoeal Disease Research Mohakhali Dhaka Bangladesh;

    Department of Paediatrics and Child Health Aga Khan University Karachi Pakistan;

    Department of Paediatrics and Child Health Aga Khan University Karachi Pakistan;

    Medical Research Council (UK) Unit Fajara Gambia GlaxoSmithKline Biologicals Global Medical;

    Medical Research Council (UK) Unit Fajara Gambia;

    Medical Research Council (UK) Unit Fajara Gambia;

    Medical Research Council (UK) Unit Fajara Gambia Daffodils Pediatrics and Family Medicine;

    Centro de Investiga??o em Saúde da Manhi?a Maputo Mozambique Instituto Nacional de Saúde Minist;

    Centro de Investiga??o em Saúde da Manhi?a Maputo Mozambique Instituto Nacional de Saúde Minist;

    Centro de Investiga??o em Saúde da Manhi?a Maputo Mozambique Instituto Nacional de Saúde Minist;

    Department of Veterans Affairs Cooperative Studies Program Coordinating Center Perry Point MD;

    Division of Foodborne Waterborne and Environmental Diseases US Centers for Disease Control and;

    Division of Foodborne Waterborne and Environmental Diseases US Centers for Disease Control and;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

    Centre for International Health University of Bergen Bergen Norway Division of Infectious;

    Department of Microbiology and Immunology University of Melbourne Royal Children's Hospital;

    Center for Vaccine Development University of Maryland School of Medicine Baltimore MD 21201;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号